Skip to content

CBD: all studies

Page 20 of 38: studies 191 to 200 of 375, newest first. Back to the CBD overview

Research

Cannabis Use and Psychosis – Modern Views on the Problem. Narrative Synthesis

Medicina 2021 A. J. Kolgashkin, П. Н. Николаев, E. J. Tetenova et al. 1 citation

Cannabis continues to be the most widely used drug worldwide. Recently, there has been two trends in the field: a liberalization of cannabis-related legislation in a number of countries, as well as an increase in the content of the psychoactive component in cannabis plant – tetrahydrocannabinol. The review covers a topic that has been little studied in Russian addiction science – cannabis use...

Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties

Journal of Translational Medicine October 2, 2020 Lara Sharpe, Justin Sinclair, Andrew Kramer et al. 122 citations

BACKGROUND: -tetrahydrocannabinol (THC) has been associated with an anxiogenic response, while anxiolytic activity has been attributed mainly to cannabidiol (CBD). In animal studies, the effects of THC are highly dose-dependent, and biphasic effects of cannabinoids on anxiety-related responses have been extensively documented. A more precise assessment is required of both the anxiolytic and...

Effects of ∆9-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies.

BMC Psychiatry August 26, 2020 Ana Maria Raymundi, Thiago R Da Silva, Jeferson M B Sohn et al.

Posttraumatic stress disorder (PTSD) may stem from the formation of aberrant and enduring aversive memories. Some PTSD patients have recreationally used Cannabis, probably aiming at relieving their symptomatology. However, it is still largely unknown whether and how Cannabis or its psychotomimetic compound Δ9-tetrahydrocannabinol (THC) attenuates the aversive/traumatic memory outcomes. Here, we...

Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: A human laboratory study.

Depression and Anxiety August 1, 2020 Reilly R Kayser, Margaret Haney, Marissa Raskin et al.

Preclinical data implicate the endocannabinoid system in the pathology underlying obsessive-compulsive disorder (OCD), while survey data have linked OCD symptoms to increased cannabis use. Cannabis products are increasingly marketed as treatments for anxiety and other OCD-related symptoms. Yet, few studies have tested the acute effects of cannabis on psychiatric symptoms in humans. We recruited...

Psicosis inducida por cannabis: características clínicas y su diferenciación con la esquizofrenia con y sin consumo de cannabis asociado

Adicciones July 14, 2020 David Rentero Martín, F. Árias, Sergio Sánchez-Romero et al. 13 citations

Cannabis use is considered an established risk factor for psychosis development. Differentiating between cannabis-induced disorders and schizophrenia is useful for prognostic and therapeutic purposes. Three inpatients groups were differentiated: cannabis-induced psychosis (CIP) (n = 69; mean age = 27.4, SD = 6.5; 82.6% males), schizophrenia with cannabis abuse or dependence (SZ + CB) (n = 57;...

DOI: 10.20882/adicciones.1251 (opens in new tab) Cannabidiol Psychosis Schizophrenia object-oriented programming Mania +3

Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition

Frontiers in Psychology May 14, 2020 Marco Colizzi, Mirella Ruggeri, Sagnik Bhattacharyya 50 citations

Research evidence suggests a dose-response relationship for the association between cannabis use and risk of psychosis. Such relationship seems to reflect not only an increased risk of psychosis as a function of frequent cannabis use, but also of high-potency cannabis use in terms of concentration of delta-9-tetrahydrocannabinol (∆9-THC), its main psychoactive component. This finding would be...

DOI: 10.3389/fpsyg.2020.00833 (opens in new tab) Cannabidiol Psychotomimetic Psychosis Hallucinogen +9

Reduced responsiveness of the reward system is associated with tolerance to cannabis impairment in chronic users

Addiction Biology December 22, 2019 Natasha L. Mason, Eef L. Theunissen, Nadia R. P. W. Hutten et al. 58 citations

Cannabis is the most commonly used illicit drug in the world. However, because of a changing legal landscape and rising interest in therapeutic utility, there is an increasing trend in (long-term) use and possibly cannabis impairment. Importantly, a growing body of evidence suggests that regular cannabis users develop tolerance to the impairing, as well as the rewarding, effects of the drug....

DOI: 10.1111/adb.12870 (opens in new tab) Cannabidiol Context archaeology Dronabinol Effects of cannabis +4

PHARMACOLOGY OF NOVAL CANNABINOIDS

International Journal of Pharmacy and Pharmaceutical Sciences December 9, 2019 S. K. Sumitha, Veena S. Pattammady, R. Sambathkumar 2 citations

Cannabis is a plant rich in various compounds that have a variety of impacts on the physiology of humans and the effects of these metabolites have a significant role in managing a variety of clinical diseases. A substantial increase in the use of SC (synthetic cannabinoids) had seen in the last few years especially infrequent cannabis users. The SCs will generate psychoactive effects that were...

DOI: 10.22159/ijpps.2020v12i1.36005 (opens in new tab) Cannabidiol Synthetic cannabinoids Pharmacology Bioavailability +8

Over eight hundred cannabis strains characterized by the relationship between their psychoactive effects, perceptual profiles, and chemical compositions

bioRxiv (Cold Spring Harbor Laboratory) September 8, 2019 Laura Alethia de la Fuente, Federico Zamberlán, Andrés Sánchez Ferrán et al. 1 citation preprint

Abstract Background Commercially available cannabis strains have multiplied in recent years as a consequence of regional changes in legislation for medicinal and recreational use. Lack of a standardized system to label plants and seeds hinders the consistent identification of particular strains with their elicited psychoactive effects. The objective of this work was to leverage information...

Reduced responsiveness of the reward system underlies tolerance to cannabis impairment in chronic users

bioRxiv (Cold Spring Harbor Laboratory) July 19, 2019 Natasha L. Mason, Eef L. Theunissen, Nadia R. P. W. Hutten et al. 4 citations preprint

Abstract Cannabis is the most commonly used illicit drug in the world. However due to a changing legal landscape, and rising interest in therapeutic utility, there is an increasing trend in (long-term) use and possibly, cannabis impairment. Importantly, a growing body of evidence suggests regular cannabis users develop tolerance to the impairing, as well as the rewarding, effects of the drug....